S. Harada et al. / Tetrahedron 69 (2013) 3264e3273
3271
benzene. The combined organic layers were washed with water
and brine, and dried over Na2SO4. Concentration and column
chromatography (hexane/AcOEt 97/3 to 90/10) gave the title
compound (61 mg, 67%) as pale yellow amorphous solid: Rf¼0.6
(hexane/AcOEt 7/3). 1H NMR: 1.66 (1H, m), 1.77e1.92 (3H, m), 2.51
(1H, ddd, J¼12.5, 4.3, 4.0), 2.56 (1H, ddd, J¼12.5, 10.4, 3.0), 3.14 (1H,
ddd, J¼10.2, 4.9, 4.6), 3.27 (3H, s), 3.48 (1H, d, J¼14.0), 3.52 (1H, d,
J¼14.0), 4.71 (1H, d, J¼4.9), 7.22e7.79 (14H, m), 8.36 (1H, m). 13C
NMR: 22.4 (CH2), 23.1 (CH2), 45.0 (CH), 47.2 (CH2), 51.1 (CH3), 55.1
(CH), 59.3 (CH2), 116.0 (CH), 117.8 (C), 119.6 (CH), 123.5 (CH), 125.0
(CH), 125.4 (CH), 126.9 (CH), 128.2 (CH), 128.6 (CH), 128.7 (CH),
129.4 (CH), 131.6 (C), 132.1 (CH), 134.6 (C), 135.4 (C), 139.5 (C), 168.5
(C), 173.3 (C). IR (neat): 2947, 1735, 1690. EIMS m/z: 452 (Mþ), 361
(MꢀBn), 347 (MꢀBz). HRMSeFAB m/z: [MþH]þ calcd for
C29H29N2O3, 453.2178; found, 453.2160.
(60% w/w dispersion in mineral oil; 32 mg, 0.80 mmol) washed
with pentane, in DMF (3 mL) was added cis-11a (200 mg,
0.57 mmol) in DMF (3 mL) over 9 min at 0 ꢁC. After 20 min, PMBCl
(0.087 mL, 0.63 mmol) was added dropwise. After the mixture was
stirred for 80 min at rt, the reaction was quenched with water. The
aqueous layer was extracted with benzene. The combined organic
layers were washed with water and brine, and dried over Na2SO4.
Concentration and column chromatography (hexane/AcOEt 90/10
to 85/15) gave the title compound (233 mg, 86%) as colorless solids
of mp 122.0e123.0 ꢁC: Rf¼0.6 (hexane/AcOEt 3/2). 1H NMR: 1.67
(1H, m), 1.81e2.00 (3H, m), 2.49 (1H, ddd, J¼11.4, 4.0, 3.6), 2.60 (1H,
ddd, J¼12.0, 11.4, 2.5), 3.13 (1H, m), 3.15 (3H, s), 3.31 (1H, d, J¼13.8),
3.51 (1H, d, J¼13.8), 3.68 (3H, s), 4.83 (1H, d, J¼4.1), 5.21 (2H, s), 6.78
(2H, d, J¼8.9), 6.94 (2H, d, J¼8.9), 7.00e7.24 (9H, m), 7.47 (1H, m).
13C NMR: 22.1 (CH2), 23.6 (CH2), 45.8 (CH), 46.8 (CH2), 49.3 (CH2),
50.7 (CH3), 55.0 (CH3), 55.4 (CH), 59.3 (CH2), 109.4 (CH), 110.4 (C),
114.0 (CH), 118.9 (CH), 119.4 (CH), 121.5 (CH), 126.5 (CH), 126.8 (CH),
127.6 (CH), 127.9 (CH), 128.7 (CH), 129.5 (C), 129.6 (C), 135.4 (C),
139.5 (C), 158.9 (C), 173.5 (C). IR (neat): 3024, 2939, 1736. EIMS m/z:
468 (Mþ), 377 (MꢀBn), 347 (MꢀPMB). Anal. Calcd for C30H32N2O3:
C, 76.90; H, 6.88; N, 5.98. Found: C, 76.90; H, 6.94; N, 5.95.
4.8.4. Methyl (2RS,3SR)-1-benzyl-2-(1-pivaloylindol-3-yl)piperidine-
3-carboxylate (cis-11d). To a stirred solution of cis-11a (70 mg,
0.20 mmol) and DMAP (30 mg, 0.24 mmol) in CH2Cl2 (4 mL), were
added Et3N (0.049 mL, 0.34 mmol) and PivCl (0.051 mL, 0.40 mmol)
dropwise at 0 ꢁC. After the mixture was stirred for 15 h at rt, an-
other portion of DMAP (49 mg, 0.40 mmol) and PivCl (0.051,
0.40 mmol) were added, and the whole was stirred for further 3 h.
The reaction was quenched by addition of saturated aq NH4Cl
(2 mL) and saturated aq NaHCO3 (4 mL). The aqueous layer was
extracted with AcOEt. The combined organic layers were washed
with 10% Na2CO3 and brine, and dried over Na2SO4. Concentration
and column chromatography (hexane/AcOEt 97/3 to 95/5) gave the
title compound (74 mg, 81%) as colorless oil: Rf¼0.6 (hexane/AcOEt
4/1). 1H NMR: 1.51 (9H, s), 1.70 (1H, m), 1.86 (1H, m), 1.95e1.99 (2H,
m), 2.51 (1H, ddd, J¼12.5, 4.3, 4.0), 2.68 (1H, ddd, J¼12.5, 10.1, 3.1),
3.16 (1H, ddd, J¼7.3, 7.3, 4.9), 3.28 (3H, s), 3.55 (2H, s), 4.63 (1H, d,
J¼4.9), 7.18e7.43 (8H, m), 7.83 (1H, s), 8.48 (1H, m). 13C NMR: 22.5
(CH2), 23.1 (CH2), 28.6 (CH3), 41.2 (C), 44.2 (CH), 47.4 (CH2), 51.2
(CH3), 55.4 (CH), 59.0 (CH2), 117.0 (CH), 117.6 (C), 119.2 (CH), 123.2
(CH),123.9 (CH),125.2 (CH),126.9 (CH),128.2 (CH),128.7 (CH),130.1
(C), 136.2 (C), 138.9 (C), 175.0 (C), 177.0 (C). IR: 2947, 1736, 1690.
EIMS m/z: 432 (Mþ), 375 (Mꢀt-Bu), 341 (MꢀBn). HRMSeFAB m/z:
[MþH]þ calcd for C27H33N2O3, 433.2491; found, 433.2501.
4.9. Table 4
4.9.1. Typical procedure(entry 4). Methyl 3-((2RS,3SR)-1-benzyl-2-(1-
benzylindol-3-yl)piperidin-3-yl)-3-oxopropanoate (13e). To a stirred
0.5 M THF solution of NaHMDS (12.4 mL, 6.2 mmol), was added
AcOMe (0.49 mL, 6.2 mmol) in THF (6 mL) over 10 min at ꢀ78 ꢁC.
After 1 h, cis-11e (170 mg, 0.39 mmol) in THF (6 mL) was added over
10 min, and the mixture was stirred for 15 h at rt. The reaction was
quenched with saturated aq NaHCO3 (10 mL), and the aqueous layer
was extracted with Et2O. The combined organic layers were washed
with brine and dried over Na2SO4. Concentration and column
chromatography (DIOL silica gel MB100-40/75, hexane/AcOEt 15/1)
gave 13e (23 mg, 12%) as yellow solids of mp 138.5e140.0 ꢁC: Rf¼0.4
(hexane/AcOEt 3/2). 1H NMR: 1.67 (1H, m), 1.81e1.97 (3H, m), 2.45
(1H, ddd, J¼11.9, 4.3, 4.0), 2.56 (1H, ddd, J¼11.9, 11.3, 2.5), 2.99 (1H,
d, J¼15.5), 3.35 (1H, d, J¼15.5), 3.36 (1H, d, J¼13.5), 3.37 (1H, m),
3.52 (3H, s), 3.58 (1H, d, J¼13.5), 4.85 (1H, d, J¼4.4), 5.32 (2H, s),
7.03 (1H, m), 7.06e7.30 (13H, m), 7.46 (1H, m). 13C NMR: 22.1 (CH2),
23.2 (CH2), 46.8 (CH2), 47.6 (CH2), 50.1 (CH2), 52.0 (CH3), 52.6 (CH),
55.1 (CH), 59.2 (CH2), 109.8 (CH), 119.1 (CH), 119.6 (CH), 122.0 (CH),
126.5 (CH), 126.8 (CH), 127.6 (CH), 127.6 (CH), 128.2 (CH), 128.6 (C),
128.7 (CH), 128.8 (CH), 129.2 (C), 135.7 (C), 137.4 (C), 139.4 (C), 167.7
(C), 203.3 (C). IR (neat): 3031, 2947, 1744, 1705, 1620, 1450. EIMS m/
z: 480 (Mþ), 389 (MꢀBn). HRMSeFAB m/z: [MþH]þ calcd for
C31H33N2O3, 481.2491; found, 481.2498: and trans-11e (115 mg,
68%) as yellow solids of mp 108.0e109.5 ꢁC: Rf¼0.6 (hexane/AcOEt
3/2). 1H NMR: 1.61e1.72 (3H, m), 1.97e2.04 (2H, m), 2.87 (1H, d,
J¼13.4), 2.98e3.09 (2H, m), 3.27 (3H, s), 3.68 (1H, d, J¼10.4), 3.92
(1H, d, J¼13.4), 5.23 (1H, d, J¼16.2), 5.29 (1H, d, J¼16.2), 7.01e7.25
(14H, m), 8.06 (1H, br s). 13C NMR: 24.7 (CH2), 28.8 (CH2), 49.7
(CH2), 50.6 (CH), 51.0 (CH3), 52.6 (CH2), 59.2 (CH2), 62.6 (CH), 109.6
(CH), 115.6 (C), 119.1 (CH), 120.9 (CH), 121.8 (CH), 126.4 (CH), 126.5
(CH), 127.0 (C), 127.2 (CH), 127.4 (CH), 127.9 (CH), 128.6 (CH), 128.9
(CH), 136.9 (C), 137.7 (C), 139.7 (C), 175.0 (C). IR (neat): 3420, 3028,
2945, 2790, 1732, 1454. EIMS m/z: 438 (Mþ), 347 (MꢀBn). Anal.
Calcd for C29H30N2O2: C, 79.42; H, 6.89; N, 6.39. Found: C, 79.51; H,
6.90; N, 6.42.
4.8.5. Methyl (2RS,3SR)-1-benzyl-2-(1-benzylindol-3-yl)piperidine-
3-carboxylate (cis-11e). To a suspension of NaH (60% w/w disper-
sion in mineral oil; 38 mg, 0.95 mmol), washed with pentane, in
DMF (4 mL) was added cis-11a (250 mg, 0.72 mmol) in DMF (3 mL)
over 5 min at 0 ꢁC. After the mixture was stirred for 25 min at rt,
BnBr (0.10 mL, 0.86 mmol) was added dropwise. After 1.2 h, to the
mixture was added water. The aqueous layer was extracted with
benzene. The combined organic layers were washed with water
and brine, and dried over Na2SO4. Concentration and column
chromatography (hexane/AcOEt 9/1 to 4/1) gave the title com-
pound (273 mg, 87%) as colorless solids of mp 128.0e128.5 ꢁC:
Rf¼0.6 (hexane/AcOEt 3/2). 1H NMR: 1.69 (1H, m), 1.85e2.00 (3H,
m), 2.50 (1H, ddd, J¼12.0, 4.0, 3.3), 2.60 (1H, J¼ddd, 12.0, 10.0, 3.1),
3.16 (1H, ddd, J¼11.0, 4.8, 4.6), 3.19 (3H, s), 3.32 (1H, d, J¼14.0), 3.53
(1H, d, J¼14.0), 4.84 (1H, d, J¼4.8), 5.33 (2H, s), 7.02e7.06 (3H, m),
7.12 (1H, m), 7.20e7.30 (10H, m), 7.49 (1H, m). 13C NMR: 22.2 (CH2),
23.6 (CH2), 45.9 (CH), 46.9 (CH2), 49.9 (CH2), 50.9 (CH3), 55.5 (CH),
59.5 (CH2), 109.4 (CH), 110.7 (C), 119.1 (CH), 119.5 (CH), 121.7 (CH),
126.4 (CH), 126.7 (CH), 127.0 (CH), 127.5 (CH), 128.1 (CH), 128.7 (CH),
128.8 (CH), 130.0 (C), 135.6 (C), 137.8 (C), 140.0 (C), 173.8 (C). IR
(neat): 3028, 2947, 2804, 1734, 1454. EIMS m/z: 438 (Mþ), 347
(MꢀBn). Anal. Calcd for C29H30N2O2: C, 79.42; H, 6.89; N, 6.39.
Found: C, 79.38; H, 6.83; N, 6.27.
4.9.2. Entry 1. Methyl 3-((2RS,3SR)-1-benzyl-2-(indol-3-yl)piperidin-
3-yl)-3-oxopropanoate (13a). To a stirred 0.5 M THF solution of
NaHMDS (2.0 mL, 1.0 mmol), was added AcOMe (0.079 mL,
1.0 mmol) in THF (1 mL) over 3 min at ꢀ78 ꢁC. After 1 h, cis-11b
(112 mg, 0.25 mmol) in THF (1 mL) was added over 4 min, and the
mixture was stirred for 2 h at ꢀ40 ꢁC. Then the cooling bath was
4.8.6. Methyl (2RS,3SR)-1-benzyl-2-(1-p-methoxybenzylindol-3-yl)
piperidine-3-carboxylate (cis-11f). To a stirred suspension of NaH